Narido Richard Clavano 4
4 · Lucira Health, Inc. · Filed Mar 13, 2023
Insider Transaction Report
Form 4
Narido Richard Clavano
Interim CFO
Transactions
- Sale
Common Stock
2023-03-03$1.00/sh−4,742$4,742→ 82,202 total - Sale
Common Stock
2023-03-07$0.45/sh−2,382$1,072→ 77,910 total - Sale
Common Stock
2023-03-06$0.57/sh−1,910$1,089→ 80,292 total - Sale
Common Stock
2023-03-03$1.07/sh−9,675$10,352→ 86,944 total - Sale
Common Stock
2023-03-03$1.14/sh−10,674$12,168→ 96,619 total